Key Responsibilities

• Lead the clinical development strategy and execution of Zenitar’s US and global hematology/oncology programs.

• Serve as the senior medical representative in FDA and other health authority interactions.

• Build and maintain relationships with leading investigators and KOLs.

• Provide medical and strategic oversight of clinical trials, including protocol development, benefit-risk assessment, safety governance, and data interpretation.

• Lead and oversee the US clinical team, CROs, medical monitors, and other external partners.

• Support regulatory submissions, including IND amendments, End-of-Phase meetings, NDA/BLA preparation, and responses to health authority questions.

• Provide clinical input to corporate strategy, business development, board discussions, and investor communications.

• Establish appropriate clinical governance, quality standards, and decision-making processes within a fast-paced biotech environment.

Key Qualifications

• MD or equivalent medical degree; board certification or advanced training in hematology/oncology is strongly preferred.

• 12+ years of innovative drug clinical development experience, including at least 5 years in hematology/oncology.

• Demonstrated leadership experience in sponsor-side Phase 2 and/or Phase 3 clinical development.

• Prior experience leading a myelofibrosis or broader MPN program, ideally involving a JAK inhibitor, is highly preferred.

• Proven experience leading FDA interactions and cross-functional global development teams.

• NDA/BLA or other late-stage regulatory submission experience is strongly preferred.

• Established relationships with leading US MF/MPN investigators would be a significant advantage.

• Ability to operate both strategically and hands-on in a small, growth-stage biotechnology company.